FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Hemant Surgical Industries IPO and Infollion Research Services IPO.
Hemant Surgical Industries IPO is a SME Book Built Issue IPO proposed to list at BSE SME while Infollion Research Services IPO is a SME Book Built Issue proposed to list at NSE SME.
Hemant Surgical Industries IPO | Infollion Research Services IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE SME | NSE SME |
Lead Managers | Hem Securities Limited | Holani Consultants Private Limited |
Registrar | Bigshare Services Pvt Ltd | Link Intime India Private Ltd |
Market Maker | Hem Finlease Private Limited | Holani Consultants Private Limited |
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Hemant Surgical Industries IPO is up to ₹24.84 Cr whereas the issue size of the Infollion Research Services IPO is up to ₹21.45 Cr. The final issue price of Hemant Surgical Industries IPO is ₹90.00 per share and of Infollion Research Services IPO is ₹82.00 per share.
Hemant Surgical Industries IPO | Infollion Research Services IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹85.00 per share | ₹80.00 per share |
Issue Price (Upper) | ₹90.00 per share | ₹82.00 per share |
Issue Price (Final) | ₹90.00 per share | ₹82.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 1600 shares | 1600 shares |
Fresh Issue Size | 27,60,000 shares | 22,24,000 shares |
Fresh Issue Size (Amount) | up to ₹24.84 Cr | up to ₹18.24 Cr |
OFS Issue Size | 3,92,000 shares | |
OFS Issue Size (Amount) | up to ₹3.21 Cr | |
Issue Size Total | 27,60,000 shares | 26,16,000 shares |
Issue Size Total (Amount) | up to ₹24.84 Cr | up to ₹21.45 Cr |
Hemant Surgical Industries IPO opens on May 24, 2023, while Infollion Research Services IPO opens on May 29, 2023. The closing date of Hemant Surgical Industries IPO and Infollion Research Services IPO is May 26, 2023, and May 31, 2023, respectively.
Hemant Surgical Industries IPO | Infollion Research Services IPO | |
---|---|---|
Anchor Bid Date | May 23, 2023 | May 26, 2023 |
Issue Open | May 24, 2023 | May 29, 2023 |
Issue Close | May 26, 2023 | May 31, 2023 |
Basis Of Allotment (Tentative) | May 31, 2023 | Jun 05, 2023 |
Initiation of Refunds (Tentative) | Jun 01, 2023 | Jun 06, 2023 |
Credit of Share (Tentative) | Jun 02, 2023 | Jun 07, 2023 |
Listing date (Tentative) | Jun 05, 2023 | Jun 08, 2023 |
Anchor Lockin End date 1 | Jun 30, 2023 | Jul 05, 2023 |
Anchor Lockin End date 2 | Aug 29, 2023 | Sep 03, 2023 |
Hemant Surgical Industries IPO P/E ratio is 12.28, as compared to Infollion Research Services IPO P/E ratio of 14.24.
Hemant Surgical Industries IPO | Infollion Research Services IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100.00% | 67.09% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 73.56% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 12.28 | 14.24 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹93.96 Cr. | ₹79.47 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 32.42%% | 42.20%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 37.98%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹10.26 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 32.42%% |
In the Hemant Surgical Industries IPO retail investors (RII) are offered 9,16,800 shares while in Infollion Research Services IPO retail investors are offered 9,16,800 shares. Qualified institutional buyers (QIB) are offered 5,23,200 shares in Hemant Surgical Industries IPO and 4,83,200 shares in Infollion Research Services IPO.
Hemant Surgical Industries IPO | Infollion Research Services IPO | |
---|---|---|
Anchor Investor Reserveration | 7,82,400 shares | 7,24,800 shares |
Market Maker Reserveration | 1,44,000 shares | 1,32,800 shares |
QIB | 5,23,200 shares | 4,83,200 shares |
NII | 3,93,600 shares | 4,04,800 shares |
RII | 9,16,800 shares | 8,70,400 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 18,33,600 shares | 17,58,400 shares |
Hemant Surgical Industries IPO subscribed 150.59x in total, whereas Infollion Research Services IPO subscribed 279.24x.
Hemant Surgical Industries IPO | Infollion Research Services IPO | |
---|---|---|
QIB (times) | 41.05x | 70.72x |
NII (times) | 277.26x | 560.71x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 158.73x | 264.10x |
Employee (times) | ||
Other (times) | ||
Total (times) | 150.59x | 279.24x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|